PointState Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-21,000
| Closed | -$5.04M | – | 81 |
|
|
2021
Q4 | $5.04M | Sell |
21,000
-44,500
| -68% | -$11.4M | 0.16% | 88 |
|
|
2021
Q3 | $18.5M | Buy |
65,500
+24,900
| +61% | +$8.16M | 0.44% | 60 |
|
|
2021
Q2 | $14.1M | Sell |
40,600
-6,800
| -14% | -$2.06M | 0.33% | 68 |
|
|
2021
Q1 | $13.3M | Buy |
47,400
+38,900
| +458% | +$10.5M | 0.37% | 70 |
|
|
2020
Q4 | $2.08M | Buy |
+8,500
| New | +$2.19M | 0.05% | 111 |
|
|
2020
Q3 | – | Sell |
-56,995
| Closed | -$15.2M | – | 107 |
|
|
2020
Q2 | $15.2M | Buy |
+56,995
| New | +$17.1M | 0.58% | 43 |
|
|
2020
Q1 | – | Sell |
-98,887
| Closed | -$29.3M | – | 71 |
|
|
2019
Q4 | $29.3M | Buy |
+98,887
| New | +$27.4M | 0.8% | 44 |
|
|
2019
Q2 | – | Sell |
-4,500
| Closed | -$1.06M | – | 115 |
|
|
2019
Q1 | $1.06M | Buy |
+4,500
| New | +$1.42M | 0.03% | 113 |
|
|
2018
Q3 | – | Sell |
-86,900
| Closed | -$25.2M | – | 144 |
|
|
2018
Q2 | $25.2M | Sell |
86,900
-60,405
| -41% | -$17M | 0.31% | 67 |
|
|
2018
Q1 | $40.3M | Sell |
147,305
-620,912
| -81% | -$193M | 0.46% | 62 |
|
|
2017
Q4 | $245M | Buy |
768,217
+493,787
| +180% | +$158M | 2.58% | 11 |
|
|
2017
Q3 | $85.9M | Buy |
274,430
+118,500
| +76% | +$35.1M | 0.85% | 36 |
|
|
2017
Q2 | $42.3M | Sell |
155,930
-177,570
| -53% | -$47M | 0.5% | 52 |
|
|
2017
Q1 | $91.2M | Buy |
+333,500
| New | +$94.3M | 1.08% | 31 |
|
|
2016
Q4 | – | Sell |
-210,000
| Closed | -$65.7M | – | 123 |
|
|
2016
Q3 | $65.7M | Buy |
+210,000
| New | +$62.2M | 0.91% | 38 |
|
|
2015
Q3 | – | Sell |
-139,200
| Closed | -$56.2M | – | 97 |
|
|
2015
Q2 | $56.2M | Sell |
139,200
-318,800
| -70% | -$128M | 0.74% | 38 |
|
|
2015
Q1 | $193M | Buy |
458,000
+333,000
| +266% | +$131M | 2.89% | 9 |
|
|
2014
Q4 | $42.4M | Buy |
+125,000
| New | +$40.4M | 0.72% | 42 |
|
Other funds holding BIIB
